Investigation of human herpesvirus 8 & Leishmania species in malignant skin tumours, psoriasis, actinic keratoses, & seborrheic keratoses: A single-center experience from Ankara, Turkey
The Indian Journal of Medical Research · 2025
DOI: 10.25259/ijmr_849_2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Indian Journal of Medical Research, 2025. Verfasst von Ayfer Bakir und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Ministry of Health, Ankara Etlik City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Keratosis, Seborrheic, Psoriasis, Leishmania, Keratosis, Actinic. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background & objectives The role of human herpesvirus-8 (HHV-8) and Leishmania species in the aetiology of malignant skin tumours and proliferative skin diseases remains a topic of debate. This study aims to analyse formalin-fixed, paraffin-embedded (FFPE) skin biopsy samples using polymerase chain reaction (PCR) to determine whether skin lesions caused by HHV-8 and Leishmania spp. resemble malignant and proliferative skin diseases and assess the role of these pathogens in disease aetiology.
Methods
In this retrospective, single-center observational study, skin biopsies were collected from 275 individuals diagnosed with malignant skin tumours, psoriasis, actinic keratoses, seborrheic keratoses, and chronic dermatitis. The presence of HHV-8 and Leishmania spp. in biopsy samples was evaluated using PCR.
Results
HHV-8 DNA was not detected in any of the samples using PCR. However, Leishmania spp. DNA was identified in 8.4 per cent of all samples (n=23). No positivity was observed in the control group ( P =0.387). Leishmania spp. DNA PCR positivity was most frequently detected in psoriasis cases (32.4%), followed by actinic keratosis (AK) (8.7%), malignant skin tumours (4.2%), and seborrheic keratosis (SK) (3.8%). When the Leishmania positivity rate in individuals diagnosed with psoriasis was compared with that of the control group, the difference was found to be significant ( P =0.002). The positivity rate in squamous cell carcinoma (SCC) (7.3%) was higher than in basal cell carcinoma (1.6%). Interpretation & conclusions The findings in this study suggests that there is no relationship between malignant and proliferative skin diseases and HHV-8. However, Leishmania spp. DNA was detected in 8.4 per cent of all samples. Biopsy-archived samples may be preferred for the differential diagnosis of Leishmania in diseases that do not respond to treatment and in atypical clinical presentations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, Ministry of Health, Ankara Etlik City Hospital, Ankara, Turkey.
- Department of Microbiology, Atilim University Faculty of Medicine, Ankara, Turkey.
- Department of Dermatology and Venerology, Ministry of Health, Ankara Etlik City Hospital, Ankara, Turkey.
- Department of Pathology, Ministry of Health, Ankara Etlik City Hospital, Ankara, Turkey.
Zitieren
APA
Bakir, A., Usluca, S., Kartal, S. P., & Alper, M. (2025). Investigation of human herpesvirus 8 & Leishmania species in malignant skin tumours, psoriasis, actinic keratoses, & seborrheic keratoses: A single-center experience from Ankara, Turkey. The Indian Journal of Medical Research. https://doi.org/10.25259/ijmr_849_2024
Vancouver
Bakir A, Usluca S, Kartal SP, Alper M. Investigation of human herpesvirus 8 & Leishmania species in malignant skin tumours, psoriasis, actinic keratoses, & seborrheic keratoses: A single-center experience from Ankara, Turkey. The Indian Journal of Medical Research. 2025. doi:10.25259/ijmr_849_2024
BibTeX
@article{Bakir2025,
author = {Bakir, Ayfer and Usluca, Selma and Kartal, Selda Pelin and Alper, Murat},
title = {Investigation of human herpesvirus 8 & Leishmania species in malignant skin tumours, psoriasis, actinic keratoses, & seborrheic keratoses: A single-center experience from Ankara, Turkey},
journal = {The Indian Journal of Medical Research},
year = {2025},
doi = {10.25259/ijmr_849_2024}
}
EUVIMED